Literature DB >> 28481640

Multiple-Breath Washout Outcomes Are Sensitive to Inflammation and Infection in Children with Cystic Fibrosis.

Kathryn A Ramsey1,2,3, Rachel E Foong1, Jasmine Grdosic1, Alana Harper1, Billy Skoric4,5, Charles Clem6, Miriam Davis6, Lidija Turkovic1, Stephen M Stick1,2,7, Stephanie D Davis6, Sarath C Ranganathan4,5,8, Graham L Hall1,2,9.   

Abstract

RATIONALE: The lung clearance index is a measure of ventilation distribution derived from the multiple-breath washout technique. The lung clearance index is increased in the presence of lower respiratory tract inflammation and infection in infants with cystic fibrosis; however, the associations during the preschool years are unknown.
OBJECTIVES: We assessed the ability of the lung clearance index to detect the presence and extent of lower respiratory tract inflammation and infection in preschool children with cystic fibrosis.
METHODS: Ventilation distribution outcomes were assessed at 82 visits with 58 children with cystic fibrosis and at 38 visits with 31 healthy children aged 3-6 years. Children with cystic fibrosis also underwent bronchoalveolar lavage fluid collection for detection of lower respiratory tract inflammation and infection. Associations between multiple-breath washout indices and the presence and extent of airway inflammation and infection were assessed using linear mixed effects models.
RESULTS: Lung clearance index was elevated in children with cystic fibrosis (mean [SD], 8.00 [1.45]) compared with healthy control subjects (6.67 [0.56]). In cystic fibrosis, the lung clearance index was elevated in individuals with lower respiratory tract infections (difference compared with uninfected [95% confidence interval], 0.62 [0.06, 1.18]) and correlated with the extent of airway inflammation.
CONCLUSIONS: These data suggest that the lung clearance index may be a useful surveillance tool for monitoring the presence and extent of lower airway inflammation and infection in preschool children with cystic fibrosis.

Entities:  

Keywords:  child; cystic fibrosis; infection; inflammation; multiple-breath washout

Mesh:

Year:  2017        PMID: 28481640     DOI: 10.1513/AnnalsATS.201611-935OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  7 in total

1.  Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation.

Authors:  Jeffrey S Wagener; Stefanie J Millar; Nicole Mayer-Hamblett; Gregory S Sawicki; Edward F McKone; Christopher H Goss; Michael W Konstan; Wayne J Morgan; David J Pasta; Richard B Moss
Journal:  J Cyst Fibros       Date:  2017-10-31       Impact factor: 5.482

2.  The clinical utility of lung clearance index in early cystic fibrosis lung disease is not impacted by the number of multiple-breath washout trials.

Authors:  Rachel E Foong; Alana J Harper; Billy Skoric; Louise King; Lidija Turkovic; Miriam Davis; Charles C Clem; Tim Rosenow; Stephanie D Davis; Sarath Ranganathan; Graham L Hall; Kathryn A Ramsey
Journal:  ERJ Open Res       Date:  2018-02-16

Review 3.  Lung function tests to monitor respiratory disease in preschool children.

Authors:  Valentina Fainardi; Enrico Lombardi
Journal:  Acta Biomed       Date:  2018-06-14

4.  Breath detection algorithms affect multiple-breath washout outcomes in pre-school and school age children.

Authors:  Marc-Alexander Oestreich; Florian Wyler; Bettina S Frauchiger; Philipp Latzin; Kathryn A Ramsey
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

Review 5.  Monitoring disease progression in childhood bronchiectasis.

Authors:  Kathryn A Ramsey; André Schultz
Journal:  Front Pediatr       Date:  2022-09-16       Impact factor: 3.569

Review 6.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

7.  Children With Asthma Have Impaired Innate Immunity and Increased Numbers of Type 2 Innate Lymphoid Cells Compared With Healthy Controls.

Authors:  Banafshe Hosseini; Bronwyn S Berthon; Malcolm R Starkey; Adam Collison; Rebecca F McLoughlin; Evan J Williams; Kristy Nichol; Peter Ab Wark; Megan E Jensen; Carla Rebeca Da Silva Sena; Katherine J Baines; Joerg Mattes; Lisa G Wood
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.